NCT07784543Not yet recruiting
Effects of Aerobic Exercise on Shoulder Pain, Disability, and Ultrasonographic Outcomes in Patients With Type 2 Diabetes Mellitus With Supraspinatus Tendinopathy
Effects of Aerobic Exercise on Shoulder Pain, Disability, and Ultrasonographic Outcomes in Patients With Type 2 Diabetes Mellitus With Supraspinatus Tendinopathy :A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 27 Aug 2026
Brief summary (registry, in English)
Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by elevated blood glucose levels over a prolonged period. If left untreated, it can lead to serious and long-term vascular and neurological complications. It is also a major cause of morbidity due to specific microvascular complications (retinopathy, nephropathy, and neuropathy), macrovascular complications (ischemic heart disease, stroke, and peripheral vascular disease), and reduced quality of life. There are studies in the literature investigating conventional and shoulder-specific treatments for various shoulder pathologies in patients with type 2 diabetes mellitus (T2DM) . However, very few studies have investigated the effectiveness of aerobic exercise. The investigators identified only one study that evaluated the effects of aerobic exercise on pain and range of motion in patients with T2DM and adhesive capsulitis. In the present study, the investigators aim to demonstrate that aerobic exercise results in statistically significant improvements in shoulder pain, functional disability, and the structural characteristics of the supraspinatus tendon, as assessed by ultrasonography and elastography, in participants with T2DM and supraspinatus tendinopathy. The investigators believe that the findings of this study will provide scientific evidence to support the development of more effective and comprehensive rehabilitation protocols for participants with diabetes and shoulder pain.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 21 Aug 2026
- Start date
- 25 Aug 2026
- Primary completion date
- 25 Jan 2027
- Lead sponsor
- Pamukkale University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07784543
What you commit to
- Study type: Interventional
- Planned participants: 24
- From 25 Aug 2026 to the primary completion date, 25 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having received shoulder rehabilitation within the past 6 months.
Other illness
- Having a history of fracture, surgery, or injection in the upper extremity within the past 6 months.
- Having a diagnosis of a neuromuscular disease, rheumatic disease, or severe cardiovascular disease.
- Having any condition that contraindicates or prevents participation in aerobic exercise.
Other
- Having a full-thickness tear of the supraspinatus tendon.
- Having advanced diabetic complications.
Who the study is looking for
- Aged 30-70 years.
- Having a diagnosis of type 2 diabetes mellitus (T2DM) for more than 1 year.
- Having unilateral or bilateral shoulder pain for at least 3 months and a diagnosis of supraspinatus tendinopathy confirmed by magnetic resonance imaging (MRI).
- Having a pain intensity score of ≥3 on the Visual Analog Scale (VAS).
- No participation in regular exercise during the past 6 months
Age in the registry: 30 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pamukkale University, Denizli Coordinator of this site? Confirm its status | Denizli | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.